Louisiana Challenges FDA Abortion Pill Rule | US News

Attorneys in Louisiana are taking the fight to federal court, arguing that FDA rules enabling mail-order abortion pills via telehealth directly undermine the state’s strict abortion ban — a clash of federal authority and state sovereignty with national implications. Since the FDA eliminated the in-person requirement in 2023, certified pharmacies can now ship mifepristone, prompting Louisiana to claim the agency ignored health risks and overstepped its bounds. The case could reshape access nationwide: a win for Louisiana might restrict mail delivery even in pro-choice states, sparking backlash from attorneys general like California’s. A New Orleans appeals court previously sided with Louisiana, but the Supreme Court temporarily halted that ruling. Medicaid costs for post-pill care also bolster Louisiana’s argument. This battle is part of a broader strategy by Republican-led states to limit abortion access as medication abortion becomes increasingly common — a legal showdown poised to redefine reproductive rights across America.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
[email protected]

This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].

View sources & latest updates:
https://sources.thednn.ai/89a05e4e6b79b816